EORTC Cancer Research Fund
EORTC Cancer Research Fund reported total assets of 475,281 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Apr 2026).
The score of EORTC Cancer Research Fund shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -4 % Total assets -77 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
EORTC Cancer Research Fund's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Apr 2026
- Year ended 31 Dec 2024filed on 17 Apr 2025
- Year ended 31 Dec 2023filed on 20 Mar 2024
- Year ended 31 Dec 2022filed on 21 Apr 2023
- Year ended 31 Dec 2021filed on 09 May 2022
EORTC Cancer Research Fund's financial analysis
Management and control of EORTC Cancer Research Fund
EORTC Cancer Research Fund's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0416.340.628
- VAT number
- BE0416340628
- Peppol
- Registered · 0208:0416340628 · as of 10 Nov 2026
- Incorporated
- 13 Sep 1976
- Registered office
- 1200 Woluwe-Saint-Lambert
- Latest accounts
- 2025 · filed on 08 Apr 2026
EORTC Cancer Research Fund has been based in Woluwe-Saint-Lambert since 1976, active in: —. For 2025, it reports a net loss of 3,188 € and equity of 308,824 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to EORTC Cancer Research Fund
Companies in the same business, of comparable size and area, outside its group.
- Cinetec Ixelles · balance sheet 456,757 €
- Sycoda Activities of agents involved in non-specialised wholesale Tournai · balance sheet 475,199 €
- AMX Activities of holding companies Andenne · balance sheet 475,403 €
- Dr. Marchoul Medical specialists activities Tongeren-Borgloon · balance sheet 475,031 €
- Cedema Rental and operating of own or leased real estate Woluwe-Saint-Lambert · balance sheet 474,993 €
- Polydent 4S Holding Uccle · balance sheet 475,587 €
- Dr. Sadowska Anna Other education n.e.c. Maaseik · balance sheet 474,953 €
- Arin Invest Mechelen · balance sheet 475,651 €
Frequently asked questions about EORTC Cancer Research Fund
What is the revenue of EORTC Cancer Research Fund?
EORTC Cancer Research Fund files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of EORTC Cancer Research Fund?
In Belgium, the VAT number is the company number prefixed with BE: BE0416340628 for EORTC Cancer Research Fund, if the company is VAT-registered. Its company number (CBE) is 0416.340.628.
Where is the registered office of EORTC Cancer Research Fund?
According to the CBE register, the registered office of EORTC Cancer Research Fund is in 1200 Woluwe-Saint-Lambert.
What is the equity of EORTC Cancer Research Fund?
At the close of the 2025 financial year, the equity of EORTC Cancer Research Fund amounts to 308,824 €, a solvency of 65.0% of total assets.
Who manages EORTC Cancer Research Fund?
The register lists 4 active mandates at EORTC Cancer Research Fund. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of EORTC Cancer Research Fund
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →